Jean-Pierre Grégoire is a Scientist with the Population Health and Optimal Health Practices Research Unit at the CHU de Québec-Laval University Research Center. He is also a Professor and a former Dean (2006-2011) at the Faculty of Pharmacy at Laval University. Professor Grégoire is a former President of the Quebec Order of Pharmacists (1993-1995) and of the Canadian Council for the Accreditation of Pharmacy Programs (2000). He is on the Evaluation Commission of the “Conférence des Doyens de Facultés de Pharmacie d’expression Française” (CIDPHARMEF) for which he has led several external assessments of Faculties of Pharmacy in France, Africa, and Asia.
Professor Grégoire is a Fellow of the International Society for Pharmacoepidemiology and of the Canadian Academy of Health Sciences.
Optimal use of drugs
In recent years, his research has focused on the optimization of drug use in chronic diseases such as hypertension, heart failure, diabetes, and schizophrenia. He has published extensively on the issue of non-adherence to drug treatments.
1050, chemin Sainte-Foy
Canada G1S 4L8
Psychosocial factors associated with pharmacists' antidepressant drug treatment monitoring.Journal Article
J Am Pharm Assoc (2003), 60 (4), pp. 548-558, 2020, ISSN: 1544-3191.
Risk of pulmonary toxicity of bleomycin and filgrastim.Journal Article
J Oncol Pharm Pract, 25 (7), pp. 1638-1644, 2019, ISSN: 1078-1552.
Measuring adherence to oral antidiabetic multi-drug treatment: Comparative validity of prescription claims-based adherence measures against hospitalization.Journal Article
Res Social Adm Pharm, 15 (6), pp. 738-743, 2019, ISSN: 1551-7411.
Response to letter to the editor related to the retraction of a trial included in a meta-analysis of interventions to enhance oral medication adherence titled "Effectiveness and content analysis of interventions to enhance oral antidiabetic drug adherence in adults with type 2 diabetes: Systematic review and meta-analysis".Journal Article
Value Health, 22 (2), pp. 264-266, 2019, ISSN: 1098-3015.
Use of non-HIV medication among people living with HIV and receiving antiretroviral treatment in Côte d'Ivoire, West Africa: A cross-sectional study.Journal Article
PLoS ONE, 14 (9), pp. e0221335, 2019.
Treatment completion and implementation by patients initiating ticagrelorJournal Article
J Popul Ther Clin Pharmacol, 26 (1), pp. e56-e67, 2019.
The Development of a Community Pharmacy-Based Intervention to Optimize Patients' Use of and Experience with Antidepressants: A Step-by-Step Demonstration of the Intervention Mapping Process.Journal Article
Pharmacy (Basel), 6 (2), 2018, ISSN: 2226-4787.
Patient perspectives on the role of community pharmacists for antidepressant treatment: A qualitative study.Journal Article
Can Pharm J (Ott), 151 (2), pp. 142-148, 2018, ISSN: 1715-1635.
Association between community pharmacy loyalty and persistence and implementation of antipsychotic treatment among individuals with schizophrenia.Journal Article
Res Social Adm Pharm, 14 (1), pp. 53-61, 2018, ISSN: 1551-7411.
Factors associated with adherence to asthma treatment with inhaled corticosteroids: A cross-sectional exploratory study.Journal Article
J Asthma, 55 (3), pp. 318-329, 2018, ISSN: 0277-0903.
- Centre de recherche du CHU de Québec - Université Laval, Subvention, Centre hospitalier universitaire de Québec - Université Laval, Centres de recherche affiliés, from 2017-01-01 to 2099-12-31
Recently finished projects
- Chaire Famille-Louis-Boivin, Subvention, Fondation de l'Université Laval, Chaires de recherche sans organismes subventionnaires, from 1997-04-01 to 2020-03-31